Dolnick Joins Next Pharmaceuticals as Director of Sales

Well-known sales professional, Deanne Dolnick has been appointed Director of Sales at Next Pharmaceuticals, Inc. Her background in nutraceutical sales, dietetics as well as education and training make her a good fit for the position at the research, development and marketing company.

Irvine,CA (PRWEB) December 7, 2005 -- Next Pharmaceuticals, Inc. has appointed well known industry sales professional Deanne Dolnick, M.S. as Director of Sales. Ms. Dolnick’s success at such companies as BI Nutraceuticals, Soft Gel Technologies, and Natrol, Inc. played a key role in her selection.

“Deanne’s background in nutraceutical sales coupled with her M.S. in dietetics and broad experience in education and training fits very well into our strategy of informing retailers and exciting consumers about the benefits of our branded ingredients” says Bob Garrison, President and CEO of Next. “We have a major new PR and educational program for 2006 that will drive consumers to seek our ingredients in consumer brands. Deanne is going to play a key role securing strategic partners as we roll out our new marketing program for Relora®, Nexrutine®, Seditol®, and Citri-Z™.”

Next Pharmaceuticals is a research and development company with a marketing emphasis that is creating new branded ingredients for healthy living beverages and dietary supplements.

###

Press Contact: Constance St. John
Company Name: THE ST. JOHN GROUP
Email: email protected from spam bots
Phone: 415-454-2243
Website: www.nextpharmaceuticals.com

¶ 11:17 AM